(Glasgow Outcome Scale, Disability Rating Scale, mortality) and ABCC8 tag-single-nucleotide polymorphisms associated with cerebral edema (rs2237982, rs7105832) across groups. Regression models determined whether trajectory groups predicted outcome. A six trajectory group model best fit the data, identifying cohorts differing in initial intracranial pressure, evolution, and number/proportion of spikes greater than 20 mm Hg. There were pattern differences in age, hemorrhage type, and craniectomy rates. ABCC8 polymorphisms differed across groups. GOS (p = 0.006), Disability Rating Scale (p = 0.001), mortality (p < 0.0001), and rs2237982 (p = 0.035) differed across groups. Unfavorable outcomes were surprisingly predicted by both low intracranial pressure trajectories and sustained intracranial hypertension. Intracranial pressure variability differed across groups (p < 0.001) and may reflect preserved/impaired intracranial elastance/compliance. Conclusions: We employed a novel approach investigating longitudinal/dynamic intracranial pressure patterns in traumatic brain injury. In a risk adjusted model, six groups were identified and predicted outcomes. If validated, trajectory modeling may be a first step toward developing a new, granular approach for intracranial pressure phenotyping in conjunction with other phenotyping tools like biomarkers and neuroimaging. This may be particularly relevant in light of changing traumatic brain injury demographics toward the elderly. (Crit Care Med 2018; 46:1792-1802) Key Words: intracranial pressure trajectory, traumatic brain injury, group based trajectory modeling, ABCC8/sulfonylurea receptor 1 I ntracranial hypertension is a key prognosticator of unfavorable outcome in severe traumatic brain injury (TBI). Its management remains a cornerstone of TBI guidelines (1) (2) (3) (4) . However, this relationship is complex. Intracranial pressure (ICP) is a dynamic product of multiple factors including an individual's cerebral elastance/compliance, mechanisms underlying cerebral edema generation/resolution, vascular dysregulation/blood volume, impact characteristics, and injury complex (4) (5) (6) . It is further influenced by nonmodifiable factors like demographics and genetics (5) . Studies, including large trials, use single/summary ICP measures to classify patients and determine treatment efficacy (5, (7) (8) (9) (10) (11) . Considering ICP as a time invariant average value potentially obscures temporal trends. Point values may also be insufficient to distinguish between an increasingly heterogeneous TBI population: the recent demographic shift toward elderly patients with increased cerebral atrophy/cerebrospinal fluid space, comorbidities, lower physiologic reserve and reduced neuroplasticity may yield fundamentally different ICP patterns, optimal thresholds, and prognostic implications (4, 6) . In an era of precision medicine, individual variations in ICP trajectories may thus contribute to accurately phenotyping TBI. Classifying ICP trajectory may be a valuable "first step" in a new approach. It lays the foundation for future studies to potentially identify patients at risk for unfavorable trajectories, ultimately providing opportunities for early or preventive interventions. Thus, we had three goals for this exploratory study: 1) to characterize temporal patterns of ICP evolution in our cohort of severe TBI patients, 2) to evaluate whether these patterns informed outcome, and 3) whether trajectory analysis added insight beyond conventional thresholds.
Group-based trajectory modeling (GBTM) is an established analytical method identifying clusters of individuals that follow a similar progression of some measure over time (12) (13) (14) . It is increasingly used in medical research (12) (13) (14) . We use GBTM to define longitudinal ICP trajectories and identify potentially distinct patterns in severe TBI. We examined the utility of generated ICP trajectory groups as outcome predictors. To interrogate the model, we explored a potential genetic contribution to group variation. Since ABCC8 encodes sulfonylurea-receptor-1 (Sur1), a putative regulator of cerebral edema in TBI, we evaluated whether ABCC8 polymorphisms with reported cerebral edema associations differed across ICP trajectory groups (15, 16) . 
METHODS

Study Design
Clinical Data Collection
Demographic and clinical information (age, gender, GCS score), primary hemorrhage patterns, and hourly ICP were collected by research assistants blinded to ABCC8 genotypes. Primary injury/hemorrhage patterns (subdural, subarachnoid, intraparenchymal contusion, epidural, intraventricular, and diffuse axonal injury [DAI]) were determined from final radiology reports of initial CT scans and confirmed with review by a trained research assistant. For patients with greater than one pattern of primary injury, the two most prominent patterns were recorded with no ordinance. Punctate CT hemorrhages suspicious for DAI were confirmed with MRI. Hourly ICP measurements from hours 1 to 120 (standard duration per our institutional protocol) after monitor placement were obtained from clamped EVD recordings (n = 353) or intraparenchymal monitors (n = 51). For EVDs, the pressure transducer was placed at the level of the tragus. Outcomes were determined by binary 6-month Glasgow Outcome Scale (GOS) score (unfavorable: GOS < 4; favorable: GOS ≥ 4), 6-month Disability Rating Scale (DRS) score (continuous), and 6-month all-cause mortality. Outcomes were determined telephonically using www.ccmjournal.org
November 2018 • Volume 46 • Number 11 standard forms for GOS and DRS by trained research technicians supervised by a licensed neuropsychologist.
DNA Collection, Tag-Single Nucleotide Polymorphism Genotyping, and Selection DNA was obtained as previously reported (5) . Twenty-three ABCC8 tag-single nucleotide polymorphisms (SNPs) were identified using HapMap(Build-36) with the tagger-algorithm pairwise approach, r 2 greater than or equal to 0.8 and minor allele frequency greater than 0.20. Genotyping using iPlexGold was performed (Agena Compact MassArray with Nanodispenser; Genomics Research Core, University of Pittsburgh, Pittsburgh, PA). Genotype analysis was performed using Typer-4.0 Assay. After quality control (Supplemental Methods, Supplemental Digital Content 2, http://links.lww.com/CCM/ D877), 410 samples were available. Two tag-SNPs, rs2237982, and rs7105832 potentially associate with traditional cerebral edema markers (15) and were selected to assess associations with ICP trajectories.
GBTM and Statistical Analysis
We used GBTM with a censored normal distribution (0-40 mm Hg) to build ICP trajectories over the initial 120 hours. We used standard methods informed by Bayesian Information Criteria to select the optimal number of groups and iteratively eliminated nonsignificant polynomial terms by performing a stepwise reduction of polynomial level to achieve the simplest final model where each trajectory group is significant at α equals to 0.05 (Supplementary Table 1 , Supplemental Digital Content 3, http://links.lww.com/CCM/D878) (12) (13) (14) 17) . Our model included time invariant risk factor adjustment for age, sex, initial GCS score, emergent craniectomy, and primary hemorrhage pattern. We repeated this procedure restricted to patients who did not undergo craniectomy and also included subsequent models where specific CT characteristics were included as risk factors (herniation, basal cistern effacement, ventricular effacement, sulcal effacement, degree of midline shift).
Analysis of variance F test and Fisher exact test were used to compare outcomes between groups. Pairwise comparisons were adjusted (Bonferroni's method). For final trajectory groups identified by multivariable risk-adjusted GBTM, we used logistic and linear regression models to determine whether groups (encoded as categorical variables) predicted outcome. HosmerLemeshow tests determined goodness of fit. The largest trajectory group was used as the reference group. For comparison, traditional multivariable linear and logistic regression models predicting 6-month outcomes from average ICP. Analyses were performed using Stata 14.0 (StataCorp, College Station, TX).
RESULTS
ICP Trajectory Groups
Six distinct trajectory groups were identified by our final model (Fig. 1) . The mean posterior probability of group membership was greater than or equal to 0.90 indicating excellent grouping (12) . ICP Characteristics. Longitudinal ICP trajectories were progressively higher with each group (Fig. 1A) . "Group 1" (n = 34) had low ICPs that gradually rose over time. "Group 2" (n = 88) had higher ICPs versus group 1 but remained persistently low. "Group 3" (n = 93) had double digit ICPs with rare spikes greater than 20 mm Hg. "Group 4" (n = 116) was the largest group and had intermittent ICP spikes greater than 20 mm Hg. ICPs in group 4 were higher than group 3 over the entire monitoring period with more frequent spikes ( Table 1 Clinical Characteristics. Median age in groups 1 (49.5) and 2 (48) was higher than other groups (Table 1) . Radiographic and craniectomy differences between groups were also evaluated.
Injury Patterns. The three most common primary injury patterns in all trajectory groups were subdurals, contusions, and subarachnoid hemorrhages ( Supplementary Fig. 2 , Supplemental Digital Content 6, http://links.lww.com/CCM/D881-legend, Supplemental Digital Content 16, http://links.lww.com/CCM/ D891). Two-hundred fifty-seven patients had greater than one injury pattern on initial CT. In all ICP trajectory groups, frontal and diffuse injuries were most common (Supplementary A legend in the top right corner identifies the individual trajectory groups. C, ICP trajectory group descriptive characteristics: this chart descriptively summarizes demographic, pattern, and outcome differences between the trajectory groups. It highlights that in group 1, the primary hemorrhage pattern is intraparenchymal contusion (IPC), subdural hemorrhage (SDH), or subarachnoid hemorrhage (SAH), ICP values remain low with a gradual rise over time and have minimal beat-beat variability. This group predicts unfavorable outcome. SDH is the primary hemorrhage pattern in group 2. ICP values are persistently low, with minimal beat-beat variability. A high proportion of these patients undergo craniectomy, and this group also predicts unfavorable outcome. Group 3 comprises of patients with intermittent ICP spikes and high variability between measurements. Although intraparenchymal hemorrhage (IPH) and SDH constitute the majority of this group, diffuse axonal injury (DAI) and intraventricular hemorrhage are disproportionately represented. Group 3 predicts favorable outcome. Group 4 patients have high, frequent ICP spikes. ICP variability is also high in this group. IPH and SDH are the predominant patterns, and this group is predictive of favorable outcome. Group 5 patients have persistent intracranial hypertension and low variability. SDH and IPH are the most common hemorrhage patterns, and the proportion of craniectomy is low. Group 5 is highly predictive of unfavorable outcome. Group 6, the smallest cohort, has severe/refractory intracranial hypertension, a high proportion of craniectomy, and unfavorable outcome. links.lww.com/CCM/D883-legend, Supplemental Digital Content 16, http://links.lww.com/CCM/D891). In group 1, 17.65% underwent craniectomy. Groups 2 (47.73%) and 6 (53.85%) had a high proportion of patients undergoing craniectomy Interestingly, a 6-group model, even in a subcohort without craniectomies, resulted in ICP trajectory groups that were almost identical ( Fig. 1B; and Supplementary Table 3 , Supplemental Digital Content 9, http://links.lww.com/CCM/ D884) suggesting, surprisingly, that the rapid decline in ICP after hour 60-75 in group 6 of this cohort was not due to a surgical intervention but potentially the natural evolution of ICP based on pathophysiologic pathways in these patients with early severe intracranial hypertension. Furthermore, although craniectomy was acute (< 24 hr) in ~ 75% of the cohort, it was acute in 100% of patients who underwent craniectomy in group 6 ( Supplementary Fig. 4A , Supplemental Digital Content 8, http://links.lww.com/CCM/D883-legend, Supplemental Digital Content 16, http://links.lww.com/CCM/ D891). ICP trajectory group 5 was the only group where the distribution of craniectomies was similar across the first 72 hours-this group had consistent intracranial hypertension both before and after craniectomy. Late craniectomies were also performed consistent with the clinical significance of late ICP rises (18) (19) (20) . GBTM replacing craniectomy from a binary risk factor adjustment variable to a continuous variable (to (Fig. 2) with a higher variance in groups 3 and 4 versus others (p < 0.001).
Six-Month TBI Outcomes Differ Across ICP Trajectory Groups Unfavorable 6-month GOS (p = 0.006), DRS (p = 0.0003), and mortality (p < 0.0001) differed across trajectory groups (Table 2 and Fig. 3) . Comparisons within ICP trajectory groups revealed that groups 1 (median age 49.5, low rising ICPs), 2 (median age 48, high proportion of craniectomy, persistently low ICPs), 5 (median age 27, persistently elevated ICP), and 6 (severe/refractory intracranial hypertension) had higher proportions of unfavorable GOS (Fig. 3A ) (all p < 0.001). Groups 3 and 4 (intermittent ICP spikes, higher variability) had higher proportions of survivors (Fig. 3B ) (both p < 0.0001). ICP trajectory group membership predicted 6-month outcome in all assessed measures ( Table 2 and increased odds of unfavorable GOS despite being at opposite extremes in terms of absolute ICP ( Fig. 1 and Table 2) . Surprisingly, these results persisted even in patients without craniectomy (Supplementary 
DISCUSSION
Understanding and managing ICP remains fundamental to TBI care and thus crucial to its phenotyping. We employed a novel, dynamic ICP measurement approach to investigate ICP patterns in TBI. This classification system addresses contemporary TBI demographics, adds nuance to time invariant point Figure 3 . Distribution of 6-mo outcomes and genotypes across intracranial pressure (ICP) trajectory groups. A, Six-month Glasgow Outcome Scale (GOS) across ICP trajectory groups: These bar graphs show the proportion of patients with favorable (GOS ≥ 4, gray) versus unfavorable (GOS < 4, black) 6-mo outcome by ICP trajectory groups. Fisher exact test showed that the proportion of unfavorable 6-mo GOS was different across trajectory groups (p = 0.006). For each trajectory group, Fisher exact test was performed to determine whether the proportion of favorable versus unfavorable outcome was significantly different (p value adjusted using Bonferroni's correction). Groups 1, 2, 5, and 6 had significantly higher proportions of unfavorable outcome. B, Six-month mortality across ICP trajectory groups: These bar graphs show the proportion of patients alive (gray) versus dead (black) at 6 mo, classified by ICP trajectory groups. Fisher exact test showed that the proportion of mortality was different across trajectory groups (p < 0.0001). For each trajectory group, Fisher exact test was performed to determine whether the proportion of alive versus dead was significantly different (p value adjusted using Bonferroni's correction). Groups 3 and 4 had significantly higher proportions of patients alive at 6 mo.
values, and may provide a foundation toward eventually developing new insights into ICP-based clinical care, patient selection, and prognostication in severe TBI.
ICP Trajectory Groups as a Novel Classification Strategy
The six distinct ICP trajectory groups identified in this study were distinguished by variable ICP patterns and clinical characteristics in the risk-adjusted model. ICP trajectory groups were independent predictors of 6-month outcome across multiple measures and questioned conventional dogma/pathophysiology. Unexpectedly, a 6-group model yielded almost identical results in terms of trajectory pattern and outcome prediction for the subcohort of patients who did not undergo craniectomy, and group membership remained constant for most patients except for those in ICP trajectory group 3 and to a lesser extent those in group 4-all of whom transitioned to group 3 in the no craniectomy cohort (Supplementary  Table 3 , Supplemental Digital Content 9, http://links.lww.com/ CCM/D884). This potentially indicates a component of innate unmeasured differences between groups, that if validated, warrant characterization. The extent to which innate differences versus therapeutic maneuvers influences ICP trajectory group membership remains unknown, as is the degree to which group membership is manipulable. These factors affect whether similar versus different ICP trajectories would be seen in patient cohorts from different centers. Our study lays the foundation to explore these important questions in future work.
Current evidence suggests intracranial hypertension (variably defined as ICP ≥ 20-25 mm Hg) and proportion of ICP spikes are associated with mortality but not morbidity in survivors (21) (22) (23) (24) . Traditional models in our cohort confirm this finding. However, trajectory-based classification results identify two surprising cohorts of patients with unfavorable outcome despite low ICP (groups 1 and 2). The reason for this association remains unknown and beyond the scope of this article; however, these groups may harbor uncaptured metrics such as differences in atrophy, cerebral compliance, neuroplasticity, neurovascular coupling. Although the association may be partially attributed to higher median ages in these groups, in group 1, the association with unfavorable outcome and mortality was true even for patients less than or equal to 50 years. Differences between trajectory groups may thus reflect other important unmeasured variability in cellular dysfunction and physiology (21, 25, 26) . Additionally, unlike mean ICP (21, 22) , ICP trajectory groups 1 and 5 predicted unfavorable outcome in survivors. We therefore posit that the dogma of using point values and identical thresholds for all patients may be insufficient to distinguish complex and dynamic physiologies after TBI: classifying patients into ICP trajectory groups serves as an initial step toward recognizing the potential importance of longitudinal temporal trends and more nuanced differences between patient groups, thus identifying potential sets of patients for future study.
The value of patterns versus point measurements has been explored. Refractory ICP predicts outcome better than absolute values (27) . ICP dose (> 20 mm Hg) may influence outcome (28) . Our trajectory group classification supports these concepts. Groups 5 and 6 had persistent intracranial hypertension and markedly increased odds of unfavorable outcome. However, these patterns do not explain the relationship between groups 1 and 2 (low ICPs) and unfavorable outcome. We hypothesize that ICP "variability" may be an important predictive consideration indicative of phenomenon such as a healthier/more responsive elastance or intact neurovascular coupling-these potentially represent an early phenotyping opportunity that warrants further exploration. Previous studies have demonstrated an association between responsiveness of physiologic variables/manifestations of intact autoregulation and TBI outcome (29)-whether this relates purely to homeostatic integrity or is influenced by interventions/systemic factors remains unknown. Thus, analogous to the prognostic value of EEG variability/reactivity or PressureReactivity Index indicating cerebrovascular reactivity (30, 31) , healthier brain tissue may have more variation in ICP measurement (groups 3 and 4). Another potential explanation is that "stiffer"/distressed brains are predictive of unfavorable outcome. Our findings may also, in a manner yet to be fully characterized, reflect response to therapy.
A high-resolution temporally dynamic ICP classification system if validated, may, in conjunction with other phenotyping variables ultimately contribute toward informing patient selection for trials, minimization of treatment-effect dilution, prespecified subgroup analyses/adaptive design trials, promoting biomarker discovery to predict trajectory, and guiding differences in thresholds for clinical care based on individual phenotypes. This will need to occur in combination with other integral (and interrelated) physiologic variables including cerebral perfusion pressure, pressure-reactivity indices/autoregulatory status, and brain tissue oxygenation. It may be valuable to explore these additional variables using longitudinal trajectory analysis in future studies. Although we did not explore a priori prediction of ICP trajectory groups, our results provide the framework for such a study.
Age and ICP Trajectory Group
The TBI landscape has evolved over the recent decades. One of the starkest differences between patients on whom clinical guidelines are based versus current epidemiology is the shift toward elderly patients (4, 6) . This is associated with different injury mechanisms, age-related comorbidities, use of preinjury antiplatelet/anticoagulants, physiologic reserve/pathophysiologic responses (including compliance, ICP), clinical courses, and outcomes. These differences may yield dissimilar ICP patterns, optimal thresholds, and prognostic implications. Groups 1 and 2 had higher median ages versus others and were independent predictors of unfavorable outcome. Group 1 retained its predictive ability even in patients less than 50 years; however, group 2 did not. In both, there were minimal no episodes of intracranial hypertension. These results raise provocative questions including the utility of ICP monitoring in patients of a certain age group/injury profile or the need for alternative treatment thresholds (4 proposed in patients greater than or equal to 55 years. Modest increases in ICP may reflect more severe injury in older patients due to age-related atrophy and/or lower compliance (4, 30) . Reduced ICP monitoring in elderly patients has also been proposed however needs to be balanced with unjustified nihilistic attitudes toward this population, who can have favorable outcomes after aggressive care (4, 6) .
Genetics and ICP Trajectory
Genetic contributions to TBI outcome are increasingly appreciated (4, 6, (32) (33) (34) . These data on cerebral edema are limited but evolving and have face validity (5, 35) . Encoded by ABCC8, Sur1 mediated water influx represents a unique pathway of cerebral edema (7, 16, 36, 37) . Inhibition with glyburide has shown promise in edema reduction in a phase II trial of stroke, and ABCC8 variation is associated with cerebral edema and TBI outcome (5, 15, 38) . It thus appeared logical to test whether ABCC8 polymorphisms (rs7105832, rs2237982) that have previously been associated with traditional cerebral edema measures (mean/peak ICP, CT edema) varied across ICP trajectory groups. In our analysis, rs2237982 genotypes differed across groups. The ABCC8/Sur1 pathway is one example of the role of genetic diversity in this process. We selected it because ABCC8 polymorphisms are likely examples of a greater pool of genetic variability in pathways influencing cerebral edema/neuroprotection. ICP trajectory group-based classification may ultimately provide a more granular reflection of molecular, genetic, and pathophysiologic differences in TBI cohorts.
Limitations
This study establishes groundwork to explore methods of early trajectory prediction; defining the minimum duration of ICP trajectory observation necessary to predict group membership was beyond the scope of this analysis. This current clinical limitation, in terms of immediate translation to bedside utility of patient categorization, is an important consideration for future work. Higher resolution data (with waveform analysis or automated minute-to-minute measurements) may provide additional potentially useful phenotyping. Our findings do not identify methods for early patient classification, targets for intervention, or analyze how different interventions may cause patients to switch trajectory groups. Serial autocorrelation lags may also be interesting to evaluate within each group since these may be indicators of the typical time scales of underlying biological processes. However, these questions cannot be answered without first identifying/characterizing trajectory patterns informing outcome. Our results lay the foundation for future phenotyping studies and biomarker development to explore biological substrates that could 1) identify patient trajectories earlier in their courses, 2) provide insight into pathophysiologic/molecular/genetic differences between trajectory groups, and 3) evaluate early/preventive therapies and potentially inform patient selection for clinical trials.
This was a single-center study prone to selection/institutional biases. However, it has the advantage of a therapeutic consistency. Replication in other centers would be informative: consistent results may indicate innate differences, whereas pattern variation may implicate management effects. Manual ICP recordings may be less sensitive than automated data (21) . Although majority of emergent craniectomies at our institution are for mass lesions rather than refractory intracranial hypertension, our data did not distinguish this or include information regarding the proportion of prophylactic craniectomies or craniectomy size. Measures of therapeutic intensity were unavailable to potentially distinguish groups (particularly 4 and 5) with regard to management variation (e.g., use of hypertonic saline, extent of craniectomy). This is a major limitation since this could modulate the ICP levels/patterns noted, as well as the impact of these trajectories on outcomes. Although ICP trajectory groups are influenced by treatment, prospective analysis of unbiased trajectories would be unethical. Nonetheless, almost identical trajectory group classification resulted in all-patients versus those without craniectomies. Late ICP rises which may be clinically important were missed (19, 20) . Our data are also subject to potential intangible chronological biases; however, the same protocol has been in place since 2006, and the only significant change between this and the earlier version was the institution of brain tissue oxygenation monitor placement (unlikely to significantly influence ICP trajectories).
Although GBTM is valuable for longitudinal predictive strategies, it forces data to be fit by smooth polynomials which can be unphysiologic. To provide limits for the model, ICP greater than 40 mm Hg was treated as equivalent ICP over this threshold may increase mortality risk (27) . Our model was risk adjusted for injury severity and primary injury pattern-however, sample size limitations prohibited meaningful statistical comparisons within subgroups of injury patterns/locations. More granular study of these variables in future studies may reveal an additional influence on outcome distinct from ICP trajectories. Larger studies, powered with sufficient patients in each subgroup, are important to discern interactions between ICP trajectory groups and injury patterns or locations and their relative effects on outcome. There may also be other (currently unknown) contributors influencing both outcome and ICP trajectories not currently captured by our model, like neurovascular uncoupling, cerebral compliance, brain tissue oxygenation/ cerebral metabolic demand. For example, an earlier pediatric study yielded an interesting patient population with low ICP and low brain tissue oxygenation (39) ; analyzing a longitudinal interaction between ICP trajectory groups and brain tissue oxygenation could provide further insight into patient subpopulations. Thus, although ICP trajectory groups provide valuable, high-resolution information, ICP (and therefore this analysis) is limited to "one piece of a complex puzzle of TBI variability"-our results provide an initial basis for future analyses to explore this in conjunction with other important physiologic variables in TBI such as cerebral perfusion pressure data, autoregulatory status, waveform analysis, brain tissue oxygenation, injury pattern and location, or electroencephalogram data. Combination of ICP trajectories with other variables is likely essential for maximal value in TBI phenotyping.
CONCLUSIONS
We report a novel ICP trajectory-based classification approach as a first step to understanding dynamic longitudinal patterns of this metric in TBI. Six ICP trajectory groups were identified that supplemented insight into the relationship between ICP and TBI outcome versus point measurements. In our risk-adjusted model, ICP trajectory groups predicted 6-month mortality and disability unexpectedly, groups with low ICP trajectories also predicted unfavorable outcome. ICP variability may reflect the state of intracranial compliance/elastance and differed across trajectory groups with favorable versus unfavorable outcomes. This approach to ICP establishes groundwork for future studies to evaluate early identification of trajectory groups, pathophysiologic differences, biomarker development, and effects of intervention. If validated and refined, ICP trajectory modeling combined with other variables including neuroimaging, biomarkers, autoregulatory status, multimodal data, and electrophysiologic data may contribute to clinical trial design, precision medicine driven care, and prognostication in TBI.
